Lack of information about how innovator company expertise and technologies apply to global health provides a significant barrier.

BIO Ventures for Global Health (BVGH) understands how companies operate, what motivates them, and what they need to make a financial commitment to global health. We also understand the needs and gaps in innovation for neglected diseases.  

Neglected diseases span multiple categories of infectious organisms, clinical symptoms, patient populations, and geographic regions. For those who are unfamiliar with neglected diseases, entering the field can at first seem daunting.

At BVGH, we create reports like the Global Health Primer to showcase opportunities for biotech engagement in global health. By connecting the dots between neglected disease product needs and scientific approaches that are well known to the biopharmaceutical industry, our Global Health Primer provides a rich source of information and a roadmap for action in the neglected disease space.

BVGH’s annual Partnering for Global Health Forum, co-sponsored by the Biotechnology Industry Organization, connects key decision makers from the global health, biopharmaceutical, academic, and donor communities to discuss, debate, and discover innovative ways to drive new product development for neglected diseases.